HTX

HEALTHLINX LIMITED - Announcements

0.00%

0.1¢

Currently unlisted.

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

HTX	Appendix 3B		21/09/11	55.11KB	Share
HTX	Sigma Aldrich sign license agreement for IgY technology	PRICE SENSITIVE	21/09/11	25.2KB	Share
HTX	Change of Director's Interest Notice		19/09/11	25.51KB	Share
HTX	Appendix 3B		19/09/11	55.47KB	Share
HTX	Section 708A Notice		19/09/11	14.11KB	Share
HTX	Appendix 3B		19/09/11	55.6KB	Share
HTX	Cancellation of unquoted options		09/09/11	26.22KB	Share
HTX	China partner appointed for OvPlex diagnostic study	PRICE SENSITIVE	09/09/11	31.2KB	Share
HTX	Section 708A Notice		07/09/11	14.12KB	Share
HTX	Appendix 3B		07/09/11	55.1KB	Share
HTX	Brandwood Biomedical appointed to manage TGA submission		07/09/11	27.43KB	Share
HTX	Shareholder Update		06/09/11	7.37MB	Share
HTX	Section 708A Notice		02/09/11	14.13KB	Share
HTX	Appendix 3B		02/09/11	55.29KB	Share
HTX	Appendix 4E and Annual Report	PRICE SENSITIVE	31/08/11	2.32MB	Share
HTX	Section 708A Notice		30/08/11	14.13KB	Share
HTX	Appendix 3B		30/08/11	55.01KB	Share
HTX	Section 708A Notice		23/08/11	19.18KB	Share
HTX	Appendix 3B		23/08/11	93.28KB	Share
HTX	Appendix 3Y X 3		22/08/11	84.8KB	Share
HTX	Appendix 3B for Share Purchase Plan Issue		22/08/11	92.94KB	Share
HTX	Section 708A Notice		22/08/11	19.18KB	Share
HTX	Appendix 3B		22/08/11	93.01KB	Share
HTX	HealthLinx Share Purchase Closure		18/08/11	31.05KB	Share
HTX	Section 708A Notice		18/08/11	19.18KB	Share
HTX	Appendix 3B		18/08/11	95.14KB	Share
HTX	Section 708A Notice		04/08/11	19.18KB	Share
HTX	Appendix 3B		04/08/11	93.65KB	Share
HTX	Section 708A Notice		01/08/11	19.18KB	Share
HTX	Appendix 3B		01/08/11	95.78KB	Share
HTX	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/11	88.78KB	Share
HTX	Appendix 3B		25/07/11	93.51KB	Share
HTX	Section 708A Cleansing Notice		25/07/11	19.17KB	Share
HTX	Change of Director's Interest Notice		21/07/11	36.88KB	Share
HTX	Appendix 3B		21/07/11	93.33KB	Share
HTX	Results of Meeting		19/07/11	32.45KB	Share
HTX	Section 708A Notice		15/07/11	19.19KB	Share
HTX	Appendix 3B		15/07/11	95.89KB	Share
HTX	SpringTree CLA terminated by mutual consent		14/07/11	30.76KB	Share
HTX	HealthLinx Independent Valuation		14/07/11	28.97KB	Share
HTX	Section 708A Notice		12/07/11	19.37KB	Share
HTX	Appendix 3B		12/07/11	96.38KB	Share
HTX	Extension of SPP closing date to 12 August 2011		05/07/11	30.42KB	Share
HTX	Appendix 3B		30/06/11	95.57KB	Share
HTX	Section 708A Notice		30/06/11	19.19KB	Share
HTX	HealthLinx secures additional equity funding	PRICE SENSITIVE	30/06/11	33.02KB	Share
HTX	HealthLinx Share Purchase Plan		22/06/11	927.7KB	Share
HTX	Notice of Extraordinary General Meeting/Proxy Form		17/06/11	942.54KB	Share
HTX	Shareholder Update		17/06/11	1.36MB	Share
HTX	HealthLinx Limited Share Purchase Plan	PRICE SENSITIVE	15/06/11	32.81KB	Share
HTX	Sales of OvPlex in Singapore exceed budget	PRICE SENSITIVE	14/06/11	32.04KB	Share
HTX	Section 708A Notice		09/06/11	19.36KB	Share
HTX	Appendix 3B		09/06/11	96.14KB	Share
HTX	Objection to HealthLinx Patent Dismissed	PRICE SENSITIVE	08/06/11	31.44KB	Share
HTX	OvPlex patent granted for Australia	PRICE SENSITIVE	03/06/11	31.85KB	Share
HTX	Collaboration with Garvan Institute on prostate cancer	PRICE SENSITIVE	17/05/11	30.26KB	Share
HTX	AGR2 Patent granted in Europe	PRICE SENSITIVE	10/05/11	28.4KB	Share
HTX	Section 708A Notice		09/05/11	19.36KB	Share
HTX	Appendix 3B		09/05/11	96.21KB	Share
HTX	US based CPC appointed as CRO to manage FDA submission		03/05/11	35.13KB	Share
HTX	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/11	103.8KB	Share
HTX	Results of Meeting		28/04/11	32.67KB	Share
HTX	Expiry of quoted options		27/04/11	29.41KB	Share
HTX	Section 708A Cleansing Notice		07/04/11	19.38KB	Share
HTX	Appendix 3B		07/04/11	96.66KB	Share
HTX	Shareholder Update		31/03/11	78.35KB	Share
HTX	Notice of Extraordinary General Meeting/Proxy Form		28/03/11	969.43KB	Share
HTX	O Six Media Group interviews Nick Gatsios with transcript		16/03/11	46.71KB	Share
HTX	Larger OvPlex study confirms 93% diagnostic efficiency	PRICE SENSITIVE	08/03/11	32.22KB	Share
HTX	Section 708A cleansing notice		07/03/11	19.35KB	Share
HTX	Appendix 3B		07/03/11	97KB	Share
HTX	Appendix 3B		02/03/11	94.28KB	Share
HTX	Appendix 4d and half year Dec10 accounts	PRICE SENSITIVE	28/02/11	256.98KB	Share
HTX	Key OvPlex patent granted	PRICE SENSITIVE	24/02/11	30.13KB	Share
HTX	Ovarian cancer diagnostic study delivers exceptional results	PRICE SENSITIVE	15/02/11	36.11KB	Share
HTX	Appendix 3B		03/02/11	93.61KB	Share
HTX	Section 708A Notice		02/02/11	19.37KB	Share
HTX	Appendix 3B		02/02/11	96.71KB	Share
HTX	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	90.55KB	Share
HTX	Results of Meeting		28/01/11	32.34KB	Share
HTX	Appendix 3B		25/01/11	93.53KB	Share
HTX	Cancellation of unquoted options		05/01/11	29.43KB	Share
HTX	Final Director's Interest Notice		04/01/11	21.74KB	Share
HTX	Section 708A cleansing notice		30/12/10	19.33KB	Share
HTX	Appendix 3B		30/12/10	96.68KB	Share
HTX	Notice of Extraordinary General Meeting/Proxy Form		24/12/10	955.97KB	Share
HTX	HealthLinx Board Change		23/12/10	41.67KB	Share
HTX	Directors and Officers Share Trading Policy		17/12/10	41.52KB	Share
HTX	Part 1 of second study confirms superior efficacy of OvPlex	PRICE SENSITIVE	15/12/10	37.89KB	Share
HTX	HealthLinx signs commercial distribution deal in South Korea	PRICE SENSITIVE	02/12/10	36.71KB	Share
HTX	Initial Director's Interest Notice		01/12/10	17.93KB	Share
HTX	Section 708A cleansing notice		30/11/10	19.34KB	Share
HTX	Appendix 3B		30/11/10	146.66KB	Share
HTX	Dr John Chiplin joins the Board of HealthLinx		30/11/10	31.39KB	Share
HTX	Excellent early results in large OvPlex ovarian cancer study	PRICE SENSITIVE	12/11/10	35.09KB	Share
HTX	Notice under section 708A		29/10/10	19.32KB	Share
HTX	Appendix 3B		29/10/10	146.41KB	Share
HTX	Appendix 4C - quarterly with commentary	PRICE SENSITIVE	28/10/10	101.56KB	Share
HTX	Results of Meeting		11/10/10	32.59KB	Share
HTX	Managing Directors Presentation to AGM		11/10/10	310.52KB	Share

HTXAppendix 3B
21/09/11		55.11KB	Share
HTXSigma Aldrich sign license agreement for IgY technology
21/09/11	PRICE SENSITIVE	25.2KB	Share
HTXChange of Director's Interest Notice
19/09/11		25.51KB	Share
HTXAppendix 3B
19/09/11		55.47KB	Share
HTXSection 708A Notice
19/09/11		14.11KB	Share
HTXAppendix 3B
19/09/11		55.6KB	Share
HTXCancellation of unquoted options
09/09/11		26.22KB	Share
HTXChina partner appointed for OvPlex diagnostic study
09/09/11	PRICE SENSITIVE	31.2KB	Share
HTXSection 708A Notice
07/09/11		14.12KB	Share
HTXAppendix 3B
07/09/11		55.1KB	Share
HTXBrandwood Biomedical appointed to manage TGA submission
07/09/11		27.43KB	Share
HTXShareholder Update
06/09/11		7.37MB	Share
HTXSection 708A Notice
02/09/11		14.13KB	Share
HTXAppendix 3B
02/09/11		55.29KB	Share
HTXAppendix 4E and Annual Report
31/08/11	PRICE SENSITIVE	2.32MB	Share
HTXSection 708A Notice
30/08/11		14.13KB	Share
HTXAppendix 3B
30/08/11		55.01KB	Share
HTXSection 708A Notice
23/08/11		19.18KB	Share
HTXAppendix 3B
23/08/11		93.28KB	Share
HTXAppendix 3Y X 3
22/08/11		84.8KB	Share
HTXAppendix 3B for Share Purchase Plan Issue
22/08/11		92.94KB	Share
HTXSection 708A Notice
22/08/11		19.18KB	Share
HTXAppendix 3B
22/08/11		93.01KB	Share
HTXHealthLinx Share Purchase Closure
18/08/11		31.05KB	Share
HTXSection 708A Notice
18/08/11		19.18KB	Share
HTXAppendix 3B
18/08/11		95.14KB	Share
HTXSection 708A Notice
04/08/11		19.18KB	Share
HTXAppendix 3B
04/08/11		93.65KB	Share
HTXSection 708A Notice
01/08/11		19.18KB	Share
HTXAppendix 3B
01/08/11		95.78KB	Share
HTXAppendix 4C - quarterly
28/07/11	PRICE SENSITIVE	88.78KB	Share
HTXAppendix 3B
25/07/11		93.51KB	Share
HTXSection 708A Cleansing Notice
25/07/11		19.17KB	Share
HTXChange of Director's Interest Notice
21/07/11		36.88KB	Share
HTXAppendix 3B
21/07/11		93.33KB	Share
HTXResults of Meeting
19/07/11		32.45KB	Share
HTXSection 708A Notice
15/07/11		19.19KB	Share
HTXAppendix 3B
15/07/11		95.89KB	Share
HTXSpringTree CLA terminated by mutual consent
14/07/11		30.76KB	Share
HTXHealthLinx Independent Valuation
14/07/11		28.97KB	Share
HTXSection 708A Notice
12/07/11		19.37KB	Share
HTXAppendix 3B
12/07/11		96.38KB	Share
HTXExtension of SPP closing date to 12 August 2011
05/07/11		30.42KB	Share
HTXAppendix 3B
30/06/11		95.57KB	Share
HTXSection 708A Notice
30/06/11		19.19KB	Share
HTXHealthLinx secures additional equity funding
30/06/11	PRICE SENSITIVE	33.02KB	Share
HTXHealthLinx Share Purchase Plan
22/06/11		927.7KB	Share
HTXNotice of Extraordinary General Meeting/Proxy Form
17/06/11		942.54KB	Share
HTXShareholder Update
17/06/11		1.36MB	Share
HTXHealthLinx Limited Share Purchase Plan
15/06/11	PRICE SENSITIVE	32.81KB	Share
HTXSales of OvPlex in Singapore exceed budget
14/06/11	PRICE SENSITIVE	32.04KB	Share
HTXSection 708A Notice
09/06/11		19.36KB	Share
HTXAppendix 3B
09/06/11		96.14KB	Share
HTXObjection to HealthLinx Patent Dismissed
08/06/11	PRICE SENSITIVE	31.44KB	Share
HTXOvPlex patent granted for Australia
03/06/11	PRICE SENSITIVE	31.85KB	Share
HTXCollaboration with Garvan Institute on prostate cancer
17/05/11	PRICE SENSITIVE	30.26KB	Share
HTXAGR2 Patent granted in Europe
10/05/11	PRICE SENSITIVE	28.4KB	Share
HTXSection 708A Notice
09/05/11		19.36KB	Share
HTXAppendix 3B
09/05/11		96.21KB	Share
HTXUS based CPC appointed as CRO to manage FDA submission
03/05/11		35.13KB	Share
HTXAppendix 4C - quarterly
29/04/11	PRICE SENSITIVE	103.8KB	Share
HTXResults of Meeting
28/04/11		32.67KB	Share
HTXExpiry of quoted options
27/04/11		29.41KB	Share
HTXSection 708A Cleansing Notice
07/04/11		19.38KB	Share
HTXAppendix 3B
07/04/11		96.66KB	Share
HTXShareholder Update
31/03/11		78.35KB	Share
HTXNotice of Extraordinary General Meeting/Proxy Form
28/03/11		969.43KB	Share
HTXO Six Media Group interviews Nick Gatsios with transcript
16/03/11		46.71KB	Share
HTXLarger OvPlex study confirms 93% diagnostic efficiency
08/03/11	PRICE SENSITIVE	32.22KB	Share
HTXSection 708A cleansing notice
07/03/11		19.35KB	Share
HTXAppendix 3B
07/03/11		97KB	Share
HTXAppendix 3B
02/03/11		94.28KB	Share
HTXAppendix 4d and half year Dec10 accounts
28/02/11	PRICE SENSITIVE	256.98KB	Share
HTXKey OvPlex patent granted
24/02/11	PRICE SENSITIVE	30.13KB	Share
HTXOvarian cancer diagnostic study delivers exceptional results
15/02/11	PRICE SENSITIVE	36.11KB	Share
HTXAppendix 3B
03/02/11		93.61KB	Share
HTXSection 708A Notice
02/02/11		19.37KB	Share
HTXAppendix 3B
02/02/11		96.71KB	Share
HTXAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	90.55KB	Share
HTXResults of Meeting
28/01/11		32.34KB	Share
HTXAppendix 3B
25/01/11		93.53KB	Share
HTXCancellation of unquoted options
05/01/11		29.43KB	Share
HTXFinal Director's Interest Notice
04/01/11		21.74KB	Share
HTXSection 708A cleansing notice
30/12/10		19.33KB	Share
HTXAppendix 3B
30/12/10		96.68KB	Share
HTXNotice of Extraordinary General Meeting/Proxy Form
24/12/10		955.97KB	Share
HTXHealthLinx Board Change
23/12/10		41.67KB	Share
HTXDirectors and Officers Share Trading Policy
17/12/10		41.52KB	Share
HTXPart 1 of second study confirms superior efficacy of OvPlex
15/12/10	PRICE SENSITIVE	37.89KB	Share
HTXHealthLinx signs commercial distribution deal in South Korea
02/12/10	PRICE SENSITIVE	36.71KB	Share
HTXInitial Director's Interest Notice
01/12/10		17.93KB	Share
HTXSection 708A cleansing notice
30/11/10		19.34KB	Share
HTXAppendix 3B
30/11/10		146.66KB	Share
HTXDr John Chiplin joins the Board of HealthLinx
30/11/10		31.39KB	Share
HTXExcellent early results in large OvPlex ovarian cancer study
12/11/10	PRICE SENSITIVE	35.09KB	Share
HTXNotice under section 708A
29/10/10		19.32KB	Share
HTXAppendix 3B
29/10/10		146.41KB	Share
HTXAppendix 4C - quarterly with commentary
28/10/10	PRICE SENSITIVE	101.56KB	Share
HTXResults of Meeting
11/10/10		32.59KB	Share
HTXManaging Directors Presentation to AGM
11/10/10		310.52KB	Share

REFRESH

First 2 3 4

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

HEALTHLINX LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Top Stories

Corporate Spotlight
Not Yet Available